blujepa
(gepotidacin)GlaxoSmithKline LLC
Usage: BLUJEPA is indicated for treating uncomplicated urinary tract infections in female patients aged 12 and older, caused by susceptible bacteria such as E. coli and Klebsiella pneumoniae. It should be used selectively to reduce drug-resistant bacteria and maintain the effectiveness of antibacterial agents.